LINDSAY KISS: Open Payments
NPI 1811587066 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64 in 3 payments from 3 companies in 2025. Trend: 2023 $112 · 2024 $71 · 2025 $64
Food & beverage: $64
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 1 | $24 |
| MILLICENT US INC | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: ZURZUVAE, FEMRING, GEMTESA.
Industry payments across CA — which companies pay providers there.
